Nawaf A. Alsaif

2.1k total citations
59 papers, 1.8k citations indexed

About

Nawaf A. Alsaif is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Nawaf A. Alsaif has authored 59 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Organic Chemistry, 28 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Nawaf A. Alsaif's work include Synthesis and biological activity (21 papers), Synthesis and Biological Evaluation (15 papers) and Quinazolinone synthesis and applications (10 papers). Nawaf A. Alsaif is often cited by papers focused on Synthesis and biological activity (21 papers), Synthesis and Biological Evaluation (15 papers) and Quinazolinone synthesis and applications (10 papers). Nawaf A. Alsaif collaborates with scholars based in Saudi Arabia, Egypt and Italy. Nawaf A. Alsaif's co-authors include Mohammed M. Alanazi, Tanveer A. Wani, Seema Zargar, Ahmad J. Obaidullah, Ahmed H. Bakheit, Abdulrahman A. Almehizia, Azmat Ali Khan, Hamad M. Alkahtani, Ibrahim H. Eissa and Mohammed A. Dahab and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and RSC Advances.

In The Last Decade

Nawaf A. Alsaif

59 papers receiving 1.8k citations

Peers

Countries citing papers authored by Nawaf A. Alsaif

Since Specialization

Citations

This map shows the geographic impact of Nawaf A. Alsaif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nawaf A. Alsaif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nawaf A. Alsaif more than expected).

Fields of papers citing papers by Nawaf A. Alsaif

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nawaf A. Alsaif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nawaf A. Alsaif. The network helps show where Nawaf A. Alsaif may publish in the future.

Co-authorship network of co-authors of Nawaf A. Alsaif

This figure shows the co-authorship network connecting the top 25 collaborators of Nawaf A. Alsaif. A scholar is included among the top collaborators of Nawaf A. Alsaif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nawaf A. Alsaif. Nawaf A. Alsaif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Purine–Hydrazone Scaffolds as Potential Dual EGFR/HER2 Inhibitors 2025 ·Pharmaceuticals ·(unknown), M. A. Bhat, Ahmed H. Bakheit, A. F. M. Motiur Rahman, Nawaf A. Alsaif, Alan M. Jones, Isolda Romero‐Canelón	1
2	Isolation, characterization, development and evaluation of phytoconstituent based formulation for diabetic neuropathy 2023 ·Saudi Pharmaceutical Journal ·Rashmi Pathak, Neetu Sachan, Atul Kabra, Ashwag S. Alanazi, Mohammed M. Alanazi, Nawaf A. Alsaif, Phool Chandra	5
3	Design, Synthesis, and Biological Evaluation of 2-Mercaptobenzoxazole Derivatives as Potential Multi-Kinase Inhibitors 2023 ·Pharmaceuticals ·Mohammed M. Alanazi, (unknown), Nawaf A. Alsaif	15
4	Design, synthesis, antitumor evaluation, and molecular docking of novel pyrrolo[2,3-d]pyrimidine as multi-kinase inhibitors 2023 ·Saudi Pharmaceutical Journal ·Ashwag S. Alanazi, (unknown), Nawaf A. Alsaif, Aisha A. Alsfouk, Mohammed M. Alanazi	13
5	Network Pharmacology- and Molecular Docking-Based Identification of Potential Phytocompounds from Argyreia capitiformis in the Treatment of Inflammation 2022 ·Evidence-based Complementary and Alternative Medicine ·Ahmad J. Obaidullah, Mohammed M. Alanazi, Nawaf A. Alsaif, Ashwag S. Alanazi, (unknown), Ahmed Z. Alanazi, Osama I. Alwassil, Ali Alqahtani, Abu Montakim Tareq	12
6	Carbonic Anhydrase Inhibition Activities of Schiff’s Bases Based on Quinazoline-Linked Benzenesulfonamide 2022 ·Molecules ·Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Hazem A. Ghabbour, Silvia Bua, Alessio Nocentini, Hamad M. Alkahtani, Nawaf A. Alsaif, Mohamed H. Al‐Agamy, Claudiu T. Supuran	13
7	Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers 2021 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Nawaf A. Alsaif, Mohammed S. Taghour, Mohammed M. Alanazi, Ahmad J. Obaidullah, Abdulrahman A. Almehizia, (unknown), (unknown), Alaa Elwan, Hazem Elkady	57
8	Charge-Transfer Complex of Linifanib with 2,3-dichloro-3,5-dicyano-1,4-benzoquinone: Synthesis, Spectroscopic Characterization, Computational Molecular Modelling and Application in the Development of Novel 96-microwell Spectrophotometric Assay 2021 ·Drug Design Development and Therapy ·Ibrahim A. Darwısh, Nasr Y. Khalil, Nawaf A. Alsaif, Rashed N. Herqash, (unknown), Hamdy M. Abdel‐Rahman	9
9	Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and in silico studies 2021 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Mohammed M. Alanazi, Alaa Elwan, Nawaf A. Alsaif, Ahmad J. Obaidullah, Hamad M. Alkahtani, Abdulrahman A. Almehizia, (unknown), Mohammed S. Taghour, Ibrahim H. Eissa	45
10	Targeting VEGFR‐2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies 2021 ·Archiv der Pharmazie ·Nawaf A. Alsaif, Hazem A. Mahdy, Mohammed M. Alanazi, Ahmad J. Obaidullah, Hamad M. Alkahtani, (unknown), (unknown), Alaa Elwan, Mohammed S. Taghour	21
11	Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies 2021 ·Bioorganic & Medicinal Chemistry ·Nawaf A. Alsaif, Mohammed S. Taghour, Mohammed M. Alanazi, Ahmad J. Obaidullah, Wael A. Alanazi, Abdullah F. Alasmari, (unknown), Mohammed A. Dahab, Hazem A. Mahdy	32
12	New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis 2021 ·Bioorganic Chemistry ·Nawaf A. Alsaif, Mohammed A. Dahab, Mohammed M. Alanazi, Ahmad J. Obaidullah, Abdulrahman A. Almehizia, (unknown), (unknown), Hazem A. Mahdy, Hazem Elkady	95
13	A Spectroscopic, Thermodynamic and Molecular Docking Study of the Binding Mechanism of Dapoxetine with Calf Thymus DNA 2020 ·South African Journal of Chemistry ·Nawaf A. Alsaif, (unknown), Ahmed H. Bakheit, Seema Zargar, Tanveer A. Wani	45
14	Interaction of an abiraterone with calf thymus DNA: Investigation with spectroscopic technique and modelling studies 2020 ·Bioorganic Chemistry ·Tanveer A. Wani, Nawaf A. Alsaif, Ahmed H. Bakheit, Seema Zargar, (unknown), Azmat Ali Khan	77
15	Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis 2020 ·Bioorganic Chemistry ·Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Nawaf A. Alsaif, Hamad M. Alkahtani, Mohammed M. Alanazi, Ahmad J. Obaidullah, (unknown), Amal Alharbi	26
16	Darunavir: A comprehensive profile 2020 ·PubMed ·Ibrahim A. Darwısh, Abdulrahman A. Al‐Majed, Nawaf A. Alsaif, Ahmed H. Bakheit, Rashed N. Herqash, (unknown)	8
17	New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment 2019 ·European Journal of Medicinal Chemistry ·Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Silvia Bua, Alessio Nocentini, Nawaf A. Alsaif, Abdulrahman A. Almehizia, Mohammed M. Alanazi, Mohamed Hefnawy, Claudiu T. Supuran	12
18	Synthesis of benzensulfonamides linked to quinazoline scaffolds as novel carbonic anhydrase inhibitors 2019 ·Bioorganic Chemistry ·Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Silvia Bua, Alessio Nocentini, (unknown), Menshawy A. Mohamed, Taghreed Z. Shawer, Nawaf A. Alsaif, Claudiu T. Supuran	41
19	Synthesis and comparative carbonic anhydrase inhibition of new Schiff’s bases incorporating benzenesulfonamide, methanesulfonamide, and methylsulfonylbenzene scaffolds 2019 ·Bioorganic Chemistry ·Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Silvia Bua, Alessio Nocentini, Mohammed M. Alanazi, Nawaf A. Alsaif, Ibrahim A. Al-Suwaidan, Mohamed Hefnawy, Claudiu T. Supuran	20
20	Mechanistic interaction study of 5,6-Dichloro-2-[2-(pyridin-2-yl)ethyl]isoindoline-1,3-dione with bovine serum albumin by spectroscopic and molecular docking approaches 2018 ·Saudi Pharmaceutical Journal ·Mohammed M. Alanazi, Abdulrahman A. Almehizia, Ahmed H. Bakheit, Nawaf A. Alsaif, Hamad M. Alkahtani, Tanveer A. Wani	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact